– Expands Illumina’s Oncology Offerings for NextSeq™ 550Dx with a Companion Diagnostic Version of TruSight™ Tumor 170 for Solid Tumors – – Loxo Oncology to Utilize a Companion Diagnostic Version of TruSight Tumor 170 for Larotrectinib (NTRK) and LOXO-292 (RET) – STAMFORD, Conn. and SAN DIEGO — Loxo Oncology (Nasdaq:LOXO) and Illumina, Inc. (Nasdaq:ILMN) today announced […]
First Personal Genomics Product Will Focus on 59 Genes Identified by the American College of Medical Genetics and Genomics (ACMG) as Highly Penetrant WALTHAM, Mass.– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with Helix, a personal genomics company, to develop and commercialize exome sequencing-based tests that will empower consumers to […]
ST. LOUIS–PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that TriCore Reference Laboratories will utilize the company’s Clinical Genomics WorkSpace™ (CGW) platform, the industry’s leading integrated workspace for genomic analytics, classification, interpretation and reporting. TriCore will join more than 50 other customers who benefit from shared interpretations in the PierianDx KnowledgeSpace, a […]
Genovis continues to expand in Asia and has signed a distribution agreement with Chayon Laboratories Inc. for the South Korean market. The agreement covers sales from Genovis’ current and future products. It was a South Korean company that had the world’s first antibody-biosimilar approved. Since then, the market for biopharmaceuticals has continued to grow strongly […]
Sponsors FIGO’s NCD Committee to Support Healthcare Community in Addressing Pregnancy-Related Diseases WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its collaboration with the International Federation of Gynecology and Obstetrics (FIGO), a not-for-profit, professional association with 130 member organizations that convenes obstetrical and gynecological associations from across the globe. FIGO […]
–CanSeq150 Initiative will use 10x Genomics’ Chromium de novo Assembly Solution to generate high quality, cost-effective assemblies for new genomes– PLEASANTON, CA.—10x Genomics, a company focused on accelerating genomic discovery, announced today a partnership with the CanSeq150 Initiative, a sequencing initiative by Canada’s Genomics Enterprise (CGEn). CanSeq150 aims to sequence 150 new genomes to support […]
Dundee, UK: Ubiquigent Limited announced today that it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel deubiquitylase (DUB) enzyme inhibitors. Under the terms of the collaboration agreement, Ubiquigent will receive an upfront payment with research support and is eligible for possible additional milestones payments. […]
Collaboration will support translational research that demonstrates the value of PGx in precision medicine PITTSBURGH — Thermo Fisher Scientific and the University of Pittsburgh have established a new Pharmacogenomics (PGx) Center of Excellence that combines expertise and technology in genomics, bioinformatics, implementation science, medication response phenotyping and education. The Center aims to discover and validate medication response predictors in […]
WALTHAM, Massachusetts – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program. Duchenne muscular dystrophy (Duchenne) is the most common genetic disorder diagnosed in childhood, affecting approximately 1 in every 5,000 live male births (about 20,000 new […]
Emmen, The Netherlands – Spark Holland B.V. (www.sparkholland.com), a leading supplier of analytical sample prep and sample introduction instrumentation, today announced an OEM deal with Axel Semrau. Axel Semrau will brand a comprehensive portfolio of Spark Holland instrumentation, adding value to its innovative hardware program by using CHRONOS software control and development of dedicated applications. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
